MPDU1 mutations underlie a novel human congenital disorder of glycosylation, designated type If
Open accessThe DOI matches its Crossref record; 4 of the 4 references it cites were found in a registry or an index.
Abstract
IntroductionCongenital disorders of glycosylation (CDG) are a family of severe inherited diseases caused by a defect in protein N-glycosylation (1-4).These multisystem disorders present with a wide variety of clinical features, such as disorders of the nervous system development, psychomotor retardation, dysmorphic features, hypotonia, coagulation disorders, and immunodeficiency.The broad spectrum of features reflects the critical role of N-glycoproteins during embryonic development, differentiation, and maintenance of cell functions (5,6).Isoelectric focusing of serum transferrin, a sialylated glycoprotein, is used as a diagnostic tool and makes it possible to distinguish two basic types of CDG: deficiencies in assembly of the core oligosaccharide or its transfer to protein are referred to as CDG-I and defects in trimming and modification of the core oligosaccharide after its transfer to protein are referred to as CDG-II (7).Several subtypes of CDG have been characterized at the biochemical and genetic level, such as the deficiency in phosphomannomutase activity, caused by a defect in the PMM2 gene (CDG-Ia) (8, 9), the deficiency in the phosphomannose isomerase activity due to a mutated PMI locus (CDG-Ib) (10, 11), mutations in the ALG6 gene resulting in a reduced dolichylphosphoglucosedependent (Dol-P-Glc-dependent) α1,3-glucosyltransferase activity (CDG-Ic) (12-15), mutations in the ALG3 gene leading to a reduced dolichylphosphomannose-dependent (Dol-P-Man-dependent) α1,3-mannosyltransferase activity (CDG-Id) (16), and a defect in the Dol-P-Man synthase activity due to mutations in the DPM1 gene (CDG-Ie) (17, 18).Furthermore, a deficiency in the Golgi enzyme N-acetylglucosaminyltransferase II leads to CDG-IIa (19), mutations in the glucosidase I gene lead to CDG-IIb (20), and an impaired transport of GDP-fucose into the Golgi apparatus causes CDG-Iic (21).The assembly of the dolichylpyrophosphate-linked oligosaccharide core is a highly conserved process that
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Intracellular Functions of N-Linked Glycans
Helenius, A., & Aebi, A. M. (2001) · Science · doi:10.1126/science.291.5512.2364 · Cited by 2,405 · cited 1×
“The broad spectrum of features reflects the critical role of N-glycoproteins during embryonic development, differentiation, and maintenance of cell functions (5, 6).”
Niehues, R., Hasilik, M., Alton, G., Körner, C., Schiebe-Sukumar, M., Koch, H. G., Zimmer, K. P., Wu, R., Harms, E., Reiter, K., et al. (1998) · Journal of Clinical Investigation · doi:10.1172/jci2350 · Cited by 422 · cited 1×
“Several subtypes of CDG have been characterized at the biochemical and genetic level, such as the deficiency in phosphomannomutase activity, caused by a defect in the PMM2 gene (CDG-Ia) (8, 9), the deficiency in the phosphomannose isomerase activity due to a mutated PMI locus (CDG-Ib) (10, 11), mutations in the ALG6 g…”
Congenital disorders of glycosylation: genetic model systems lead the way
Aebi, M. (2001) · Trends in Cell Biology · doi:10.1016/s0962-8924(01)01925-0 · Cited by 167
Self-citationChapman, A., Trowbridge, I. S., Hyman, R., & Kornfeld, S. (1979) · Cell · doi:10.1016/0092-8674(79)90259-9 · Cited by 123
Research works printed but not linked: 44
- Freeze, 1999, Biochim Biophys Acta, 1455, 167, 10.1016/S0925-4439(99)00072-1 · DOI
- Krasnewich, 1997, Adv Pediatr, 44, 109, 10.1016/S0065-3101(24)00050-1 · DOI · Paper page
- 10.1093/glycob/3.2.97 · DOI · Paper page
- Aebi, 2000, Glycobiology, 10, III-V
- 10.1016/0014-5793(95)01357-1 · DOI · Paper page
- 10.1038/ng0597-88 · DOI · Paper page
- 10.1086/301873 · DOI · Paper page
- 10.1172/JCI2266 · DOI · Paper page
- 10.1073/pnas.96.12.6982 · DOI · Paper page
- 10.1007/s004390050022 · DOI
- 10.1073/pnas.95.22.13200 · DOI · Paper page
- 10.1093/emboj/18.23.6816 · DOI
- 10.1172/JCI8691 · DOI · Paper page
- 10.1172/JCI7302 · DOI · Paper page
- Jaeken, 1994, Arch Disease Childhood, 71, 123, 10.1136/adc.71.2.123 · DOI · Paper page
- 10.1086/302948 · DOI · Paper page
- 10.1074/jbc.274.37.25986 · DOI · Paper page
- Burda, 1999, Biochim Biophys Acta, 1426, 239, 10.1016/S0304-4165(98)00127-5 · DOI · Paper page
- 10.1146/annurev.bi.56.070187.000431 · DOI · Paper page
- 10.1006/bbrc.1999.1886 · DOI
- Silberstein, 1996, FASEB J, 10, 849, 10.1096/fasebj.10.8.8666161 · DOI · Paper page
- Knauer, 1999, Biochim Biophys Acta, 1426, 259, 10.1016/S0304-4165(98)00128-7 · DOI · Paper page
- 10.1074/jbc.R000022200 · DOI · Paper page
- Anand, 2001, Mol Biol Cell, 12, 487, 10.1091/mbc.12.2.487 · DOI · Paper page
- 10.1002/elps.1150090921 · DOI
- Zufferey, 1995, EMBO J, 14, 4949, 10.1002/j.1460-2075.1995.tb00178.x · DOI · Paper page
- 10.1002/bmc.1130030106 · doi:10.1002/bmc.1130030106
- 10.1093/nar/18.12.3587 · DOI · Paper page
- Yamashita, 1993, J Biol Chem, 268, 5783, 10.1016/S0021-9258(18)53387-1 · DOI · Paper page
- 10.1093/glycob/9.6.617 · DOI · Paper page
- Herscovics, 1999, Biochim Biophys Acta, 1426, 275, 10.1016/S0304-4165(98)00129-9 · DOI
- 10.1042/0264-6021:3480001 · doi:10.1042/0264-6021:3480001 · Paper page
- 10.1083/jcb.98.1.35 · doi:10.1083/jcb.98.1.35
- Rosenwald, 1989, Mol Cell Biol, 9, 914, 10.1128/MCB.9.3.914 · DOI
- 10.1016/0163-7827(85)90008-6 · DOI · Paper page
- Zeng, 1990, J Biol Chem, 265, 2296, 10.1016/S0021-9258(19)39975-2 · DOI
- Camp, 1993, J Biol Chem, 268, 6721, 10.1016/S0021-9258(18)53309-3 · doi:10.1016/s0021-9258(18)53309-3
- 10.1083/jcb.130.3.529 · DOI
- 10.1093/glycob/8.12.1195 · DOI
- Chojnacki, 1988, Biochem J, 251, 1, 10.1042/bj2510001 · DOI · Paper page
- Valtersson, 1985, J Biol Chem, 260, 2742, 10.1016/S0021-9258(18)89424-8 · DOI · Paper page
- 10.1093/glycob/4.6.909 · doi:10.1093/glycob/4.6.909
- Lehrman, 1989, J Biol Chem, 264, 1584, 10.1016/S0021-9258(18)94227-4 · doi:10.1016/s0021-9258(18)94227-4
- 10.1093/glycob/10.1.77 · DOI
Cited by
Base editing: precision chemistry on the genome and transcriptome of living cells
Rees, H. A., & Liu, D. R. (2018) · Nature Reviews Genetics · doi:10.1038/s41576-018-0059-1 · Cited by 1,675
Improving cytidine and adenine base editors by expression optimization and ancestral reconstruction
Koblan, L. W., Doman, J. L., Wilson, C., Levy, J. M., Tay, T., Newby, G. A., Maianti, J. P., Raguram, A., & Liu, D. R. (2018) · Nature Biotechnology · doi:10.1038/nbt.4172 · Cited by 944
Marquardt, T., & Denecke, J. (2003) · European Journal of Pediatrics · doi:10.1007/s00431-002-1136-0 · Cited by 290
A pseudoautosomal glycosylation disorder prompts the revision of dolichol biosynthesis
Wilson, M. P., Kentache, T., Althoff, C. R., Schulz, C., de Bettignies, G., Mateu Cabrera, G., Cimbalistiene, L., Burnyte, B., Yoon, G., Costain, G., et al. (2024) · Cell · doi:10.1016/j.cell.2024.04.041 · Cited by 30
Self-citation
Metadata
- Authors
- Schenk, B., Imbach, T., Frank, C. G., Grubenmann, C. E., Raymond, G. V., Hurvitz, H., Raas-Rotschild, A., Luder, A. S., Jaeken, J., Berger, E. G., Matthijs, G., Hennet, T., & Aebi, M.
- Venue
- Journal of Clinical Investigation
- Published
- 2001-12-01
- Volume
- 108
- Issue
- 11
- Pages
- 1687-1695
- ISSN
- 0021-9738 (ISSN-L)
- OpenAlex
- W4255361792
- Cited by
- 41
- References
- 4
- FWCI
- 0.98
- Type
- journal article
- Language
- en
- Open access
- bronze
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
How to cite
Cite CoChat for the checks on this page, and the paper for its own findings.
- This page
- CoChat. (2026). Citation check: MPDU1 mutations underlie a novel human congenital disorder of glycosylation, designated type If. https://app.cochat.ai/papers/10.1172/jci13419
- The paper
- Schenk, B., Imbach, T., Frank, C. G., Grubenmann, C. E., Raymond, G. V., Hurvitz, H., Raas-Rotschild, A., Luder, A. S., Jaeken, J., Berger, E. G., Matthijs, G., Hennet, T., & Aebi, M. (2001). MPDU1 mutations underlie a novel human congenital disorder of glycosylation, designated type If. Journal of Clinical Investigation. https://doi.org/10.1172/jci13419
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.